Your session is about to expire
← Back to Search
Benzodiazepine Taper + Cognitive Behavioral Therapy for Substance Use Disorder
N/A
Recruiting
Research Sponsored by University of California, Los Angeles
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, bi-weekly for the duration of treatment (up to 20 weeks), post-treatment (at 20 weeks post baseline), and at 2-month follow-up
Awards & highlights
Study Summary
This trial will measure if an online therapy + tapering program can help reduce opioid use in patients prescribed pain meds.
Eligible Conditions
- Anxiety Disorders
- Substance Use Disorder
- Chronic Pain
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, weekly for the duration of treatment (up to 20 weeks), post-treatment (at 20 weeks post baseline), and at 2-month follow-up
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, weekly for the duration of treatment (up to 20 weeks), post-treatment (at 20 weeks post baseline), and at 2-month follow-up
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Depression, Anxiety, & Stress Scale
Secondary outcome measures
Anxiety Sensitivity Index
Pain Catastrophizing Scale
Timeline Followback
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: CBT + BZ-TPExperimental Treatment2 Interventions
Participants in this condition will receive telehealth-delivered Cognitive Behavioral Therapy (CBT) in addition to the benzodiazepine taper (BZ-TP) treatment.
Group II: HE + BZ-TPActive Control2 Interventions
Participants in this condition will receive telehealth-delivered health education in addition to the benzodiazepine taper (BZ-TP) treatment.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cognitive Behavioral Therapy (CBT)
2008
Completed Phase 4
~3620
Find a Location
Who is running the clinical trial?
UCLA Health MPTF Toluca Lake Primary Care ClinicUNKNOWN
University of California, Los AngelesLead Sponsor
1,530 Previous Clinical Trials
10,278,148 Total Patients Enrolled
31 Trials studying Anxiety Disorders
3,649 Patients Enrolled for Anxiety Disorders
Boston UniversityOTHER
454 Previous Clinical Trials
9,941,516 Total Patients Enrolled
9 Trials studying Anxiety Disorders
2,309 Patients Enrolled for Anxiety Disorders
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have taken drugs other than benzodiazepines and opioids in the last 30 days, except for occasional cannabis use.You have a medical condition that needs you to keep taking benzodiazepines regularly.You have been taking prescribed BZs (benzodiazepines) for at least 3 months before the study starts and have a positive urine test for BZs at the beginning of the study.You are between 18 and 85 years old.You are feeling really upset or struggling a lot because of your anxiety symptoms.You have severe mental health symptoms that need more intense treatment, such as severe thoughts of suicide or uncontrolled manic or psychotic symptoms.You have been taking prescription opioids for at least 3 months for pain and have a positive urine test for these opioids at the start of the study.You drink more alcohol than what is considered safe according to US Dietary Guidelines.You have significant problems with thinking and memory.
Research Study Groups:
This trial has the following groups:- Group 1: CBT + BZ-TP
- Group 2: HE + BZ-TP
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Does this trial allow for participation from individuals aged 20 and above?
"Participants who meet the qualifications to join this medical trial must be between 18 and 85 years old. Notably, there are 441 separate studies dedicated to those under 18 and 1,389 devoted exclusively for senior citizens over 65."
Answered by AI
Is this research opportunity actively seeking participants?
"According to the data on clinicaltrials.gov, this medical trial is still searching for participants. It has been running since January 31st of 2023 and was last updated April 25th of the same year."
Answered by AI
What is the estimated enrollment size for this clinical research?
"Affirmative. According to clinicaltrials.gov, this research endeavour is currently seeking participants after being first posted on January 31st 2023 and edited most recently in April 25th of the same year. 54 volunteers are needed from a single site for it to be successful."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger